Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 11, 2025 • 6:01 PM ET

Date/Time Source News Release
06/11/2025 10:00 AM EDT ACCESS Newswire First Study Site Established for Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
06/09/2025 04:15 PM EDT ACCESS Newswire REMINDER: Jaguar Health to Conduct Fireside Chat 9AM ET June 10 as Part of Lytham Partners' Spring 2025 Spotlight Series
06/09/2025 09:00 AM EDT ACCESS Newswire Jaguar Health Provides Update on Meeting with FDA Discussing Statistically Significant Results of Responder Analysis of Breast Cancer Patients in Phase 3 OnTarget Trial and Potential Approval Pathway for Crofelemer
06/06/2025 09:00 AM EDT ACCESS Newswire Jaguar Health to Conduct Fireside Chat June 10 Regarding Company's Efforts to Further its Orphan Disease Development Programs as Part of Lytham Partners' Spring 2025 Spotlight Series
05/21/2025 08:00 AM EDT ACCESS Newswire Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
05/20/2025 09:15 AM EDT ACCESS Newswire First Patient Randomized in Jaguar Health's Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Crofelemer in Pediatric Patients with Microvillus Inclusion Disease (MVID)
05/15/2025 02:30 PM EDT ACCESS Newswire Jaguar Health Reports First Quarter 2025 Financials
05/14/2025 09:00 AM EDT ACCESS Newswire Jaguar Health to Hold Investor Webcast Thursday, May 15 at 4:15 PM Eastern Regarding Q1 2025 Financials & Corporate Updates
05/08/2025 09:30 AM EDT ACCESS Newswire Jaguar Health Celebrates National Pet Cancer Awareness Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs
05/07/2025 09:15 AM EDT ACCESS Newswire Jaguar Health Provides Overview of 2025 Crofelemer-Related Catalysts
Page

Additional News

As of June 11, 2025 • 6:01 PM ET

Date/Time Source News Release
05/21/2025 08:12 AM EDT SeekingAlpha Jaguar Health prices 0.25M shares at $6.09 in registered direct offering
05/15/2025 08:45 PM EDT SeekingAlpha Jaguar Health outlines rare disease catalyst convergence and expedited regulatory pathways for crofelemer following proof-of-concept results
05/15/2025 08:43 PM EDT SeekingAlpha Jaguar Health, Inc. (JAGX) Q1 2025 Earnings Call Transcript
05/15/2025 04:01 PM EDT SeekingAlpha Jaguar Health GAAP EPS of -$16.70, revenue of $2.21M
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - Jaguar Health Inc.
04/25/2025 11:37 AM EDT InvestorBrandNetwork Jaguar Health Inc. (NASDAQ: JAGX) Rises Sharply in 4/25 Early Trading Session
04/15/2025 04:43 PM EDT SeekingAlpha Jaguar Health files to sell 1.29M shares of common stock for holders
04/06/2025 06:49 PM EDT KlickAnalytics JAGX - Historical Price Movements Surrounding Earnings
04/06/2025 06:44 PM EDT KlickAnalytics JAGX - Historical Earnings Price Analysis
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.